REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 70 filers reported holding REGULUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 3.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $39,000 | -39.1% | 17,150 | -12.1% | 0.00% | – |
| Q3 2016 | $64,000 | +36.2% | 19,504 | +21.2% | 0.00% | – |
| Q2 2016 | $47,000 | -46.6% | 16,099 | +27.4% | 0.00% | – |
| Q1 2016 | $88,000 | -20.0% | 12,638 | 0.0% | 0.00% | – |
| Q4 2015 | $110,000 | -5.2% | 12,638 | -28.6% | 0.00% | – |
| Q3 2015 | $116,000 | -41.1% | 17,701 | -1.3% | 0.00% | – |
| Q2 2015 | $197,000 | +13.2% | 17,943 | +74.3% | 0.00% | – |
| Q1 2015 | $174,000 | +22.5% | 10,293 | +16.2% | 0.00% | – |
| Q4 2014 | $142,000 | -89.5% | 8,855 | -95.5% | 0.00% | -100.0% |
| Q3 2014 | $1,352,000 | -23.9% | 197,966 | -10.4% | 0.00% | -50.0% |
| Q2 2014 | $1,777,000 | -10.7% | 221,027 | +0.1% | 0.00% | 0.0% |
| Q1 2014 | $1,991,000 | +78.7% | 220,731 | +46.4% | 0.00% | +100.0% |
| Q4 2013 | $1,114,000 | +2270.2% | 150,799 | +2896.2% | 0.00% | – |
| Q3 2013 | $47,000 | +6.8% | 5,033 | +13.0% | 0.00% | – |
| Q2 2013 | $44,000 | – | 4,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,790,476 | $41,544,000 | 4.18% |
| Foresite Capital Management II, LLC | 893,781 | $9,796,000 | 3.44% |
| Abingworth LLP | 327,350 | $3,588,000 | 1.63% |
| Cormorant Asset Management, LP | 896,522 | $9,826,000 | 1.31% |
| Trellus Management Company, LLC | 80,000 | $877,000 | 0.99% |
| ORACLE INVESTMENT MANAGEMENT INC | 741,804 | $8,130,000 | 0.99% |
| WEDBUSH SECURITIES INC | 93,165 | $1,021,000 | 0.19% |
| SABBY MANAGEMENT, LLC | 344,667 | $3,778,000 | 0.14% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,260 | $222,000 | 0.13% |
| Perceptive Advisors | 200,000 | $2,196,000 | 0.13% |